Coby's clients trust him to handle complex corporate transactions with a clear understanding of their business goals. With particular experience in domestic and cross-border mergers and acquisitions, he helps clients close deals creatively while mitigating risk.

Overview
Representative Matters
Insights
Awards

From family owned businesses to NYSE-listed chemical companies, Coby’s varied clients count on his results-focused, problem-solving approach to corporate transactions.

In his 20-plus years of practice, Coby has worked with his clients to help them complete a variety of domestic and international transactions, including many acquisitions, divestitures, and joint ventures in the chemical industry; formation of international joint ventures in the health care and security services industries; and purchases and sales of family owned businesses.

Coby also assists clients with corporate reorganizations and private placements and advises clients with respect to general corporate law issues.

  • Represented a NYSE-listed electronics manufacturer in its $160 million purchase of an antenna business.
  • Represent the largest privately held rendering company in connection with its acquisitions.
  • Represented a NYSE-listed energy company in connection with its formation of a renewable energy and natural gas joint venture.
  • Represented a privately held vaping company in connection with a significant third-party investment.
  • Represented a U.S. paper manufacturer in its sale and leaseback of a U.S. paper mill.
  • Represented the sponsor in the formation of a US$75 million Hong Kong-based private equity fund focused on companies with operations in China.
  • Represented a NYSE-listed security services company in connection with its purchase of a majority stake in a China-based security services firm.
  • Represented a PRC-based portfolio company of a global private equity fund in connection with the restructuring of its preferred equity.
  • Represented a private equity fund in connection with its purchase of $50 million of convertible notes and warrants from a Nasdaq-traded biotechnology company.
  • Represented a private equity fund in connection with its purchase of jetcard membership, retail charter broker, and fuel management businesses.
  • Represented a private equity fund in its purchase of convertible debt and equity issued by an offshore holding company of a Chinese enterprise.
  • Represented a NYSE-listed product packaging company in its purchase of a majority stake in an Indian manufacturing company.
  • Represented a NYSE-listed specialty chemical company in connection with its purchase of an Ohio-based specialty chemical company quoted on the OTCBB.
  • Represented a private equity fund in its acquisition of a 70-store retail shoe and apparel business.
  • Represented a China-based portfolio company in an offshore bridge financing.
  • Represented a NYSE-listed U.S. specialty chemical company in its offshore affiliate’s purchase of a controlling stake in two Sino-foreign equity joint ventures in China.
  • Advised a U.S. logistics company in connection with the formation of a Sino-foreign equity joint venture with a Chinese transportation company.
  • Assisted U.S.-based companies with their restructurings of WFOEs and Hong Kong companies.
  • Represented a NYSE-listed U.S. specialty chemical company in connection with the formation of a Sino-foreign equity joint venture.
  • Represented a U.S.-based conglomerate in its purchase of a China-based manufacturing business.
  • Represented a NYSE-listed U.S. specialty chemical company in connection with its $763 million purchase of a division of a Dutch chemical company with operations in more than a dozen countries.
  • Represented a NYSE-listed auto parts manufacturer and its affiliates in connection with more than 25 divestitures.
  • Represented a U.S.-based medical device manufacturer in its purchase of an Italian medical device manufacturer.
  • Represented a Virginia-based, publicly traded, wholesale distributor of mechanical equipment and supplies in its sale to a private equity fund.
  • Represents a NYSE-listed specialty chemical company in connection with its establishment, dissolution, and restructurings of its worldwide subsidiaries, branches, and liaison offices.
  • Best Lawyers in America®: Corporate Law (2021-2026), Mergers and Acquisitions Law (2021-2026)
  • Thomson Reuters Stand-out Lawyer (2018, 2020-2021) – independently rated lawyers
  • Law & Politics: “Super Lawyer” in Mergers & Acquisitions(2012-2018)
  • BTI Client Service All-Star (2016)
  • Virginia Business Magazine: “Legal Elite” Under 40 (2009-2010)

From family owned businesses to NYSE-listed chemical companies, Coby’s varied clients count on his results-focused, problem-solving approach to corporate transactions.

In his 20-plus years of practice, Coby has worked with his clients to help them complete a variety of domestic and international transactions, including many acquisitions, divestitures, and joint ventures in the chemical industry; formation of international joint ventures in the health care and security services industries; and purchases and sales of family owned businesses.

Coby also assists clients with corporate reorganizations and private placements and advises clients with respect to general corporate law issues.

  • Represented a NYSE-listed electronics manufacturer in its $160 million purchase of an antenna business.
  • Represent the largest privately held rendering company in connection with its acquisitions.
  • Represented a NYSE-listed energy company in connection with its formation of a renewable energy and natural gas joint venture.
  • Represented a privately held vaping company in connection with a significant third-party investment.
  • Represented a U.S. paper manufacturer in its sale and leaseback of a U.S. paper mill.
  • Represented the sponsor in the formation of a US$75 million Hong Kong-based private equity fund focused on companies with operations in China.
  • Represented a NYSE-listed security services company in connection with its purchase of a majority stake in a China-based security services firm.
  • Represented a PRC-based portfolio company of a global private equity fund in connection with the restructuring of its preferred equity.
  • Represented a private equity fund in connection with its purchase of $50 million of convertible notes and warrants from a Nasdaq-traded biotechnology company.
  • Represented a private equity fund in connection with its purchase of jetcard membership, retail charter broker, and fuel management businesses.
  • Represented a private equity fund in its purchase of convertible debt and equity issued by an offshore holding company of a Chinese enterprise.
  • Represented a NYSE-listed product packaging company in its purchase of a majority stake in an Indian manufacturing company.
  • Represented a NYSE-listed specialty chemical company in connection with its purchase of an Ohio-based specialty chemical company quoted on the OTCBB.
  • Represented a private equity fund in its acquisition of a 70-store retail shoe and apparel business.
  • Represented a China-based portfolio company in an offshore bridge financing.
  • Represented a NYSE-listed U.S. specialty chemical company in its offshore affiliate’s purchase of a controlling stake in two Sino-foreign equity joint ventures in China.
  • Advised a U.S. logistics company in connection with the formation of a Sino-foreign equity joint venture with a Chinese transportation company.
  • Assisted U.S.-based companies with their restructurings of WFOEs and Hong Kong companies.
  • Represented a NYSE-listed U.S. specialty chemical company in connection with the formation of a Sino-foreign equity joint venture.
  • Represented a U.S.-based conglomerate in its purchase of a China-based manufacturing business.
  • Represented a NYSE-listed U.S. specialty chemical company in connection with its $763 million purchase of a division of a Dutch chemical company with operations in more than a dozen countries.
  • Represented a NYSE-listed auto parts manufacturer and its affiliates in connection with more than 25 divestitures.
  • Represented a U.S.-based medical device manufacturer in its purchase of an Italian medical device manufacturer.
  • Represented a Virginia-based, publicly traded, wholesale distributor of mechanical equipment and supplies in its sale to a private equity fund.
  • Represents a NYSE-listed specialty chemical company in connection with its establishment, dissolution, and restructurings of its worldwide subsidiaries, branches, and liaison offices.
  • Best Lawyers in America®: Corporate Law (2021-2026), Mergers and Acquisitions Law (2021-2026)
  • Thomson Reuters Stand-out Lawyer (2018, 2020-2021) – independently rated lawyers
  • Law & Politics: “Super Lawyer” in Mergers & Acquisitions(2012-2018)
  • BTI Client Service All-Star (2016)
  • Virginia Business Magazine: “Legal Elite” Under 40 (2009-2010)
  • Member, Virginia State Bar Association
  • Member, Advisory Board, Greater Richmond SCAN (Stop Child Abuse Now) Inc. (2018-present)

Education

  • William & Mary Law School, J.D., Order of the Coif, 1998
  • College of William & Mary, B.A., 1993

Bar Admissions

  • Virginia
  • Speaker, “Challenges of Modern Cross-Border Transactions,” William & Mary Law School, Business Law Society Symposium, October 2012.
  • Speaker, “Ramping Up: Managing Transaction Risk in the Current Economy,” Virginia Bar Association Business Law Section, July 2011.
  • Speaker, “Managing Legal Risk in China,” Troutman Sanders China Seminar, May 2011.
  • Speaker, “China’s Changing Business Environment,” Virginia International Business Council, November 2010.
  • Speaker, “Legal Aspects to Doing Business in China,” Virginia Asian Chamber of Commerce, March 2010.
  • Speaker, “Practical Considerations for M&A in China,” 5th Annual Legal, Tax and Financial Strategies for Doing Business in China, December 2007.
  • Speaker, “Corporate, Immigration and Tax Concerns for Chinese Businesses Doing Business in the United States,” Hampton Roads Economic Development Alliance, May 2007.